MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BROWN, N. A.
Right arrow Articles by WOLLERT, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BROWN, N. A.
Right arrow Articles by WOLLERT, U.

Molecular Pharmacology, Vol 13, 70-79, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Optical Studies on the Mechanism of the Interaction of the Enantiomers of the Anticoagulant Drugs Phenprocoumon and Warfarin with Human Serum Albumin

NIGEL A. BROWN 1, EBERHARD JÄHNCHEN 1, WALTER E. MÜLLER 1, and UWE WOLLERT 1

1 Pharmakologisches Institut der Universität, D-6500 Mainz, Federal Republic of Germany

The interaction of the racemates and enantiomers of phenprocoumon and warfarin with human serum albumin was investigated using equilibrium dialysis and circular dichroism measurements. It was found that the human serum albumin molecule binds phenprocoumon stereospecifically, with about a 2-fold higher association constant for the S(-)isomer. The stereospecificity of phenprocoumon binding is more pronounced than that of the warfarin enantiomers. Binding to human serum albumin induces Cotton effects in the enantiomers of phenprocoumon and warfarin, which superimpose upon the intrinsic Cotton effects of the drugs. The induced Cotton effects are similar in sign for the two phenprocoumon isomers, but dissimilar for the warfarin isomers. Therefore it is concluded that the orientation of the 4-hydroxycoumarin nucleus is the same for the phenprocoumon isomers, but different for the warfarin isomers, when bound to human serum albumin. This can explain differences in the stereoselective binding of the two drugs to human serum albumin.

Note:
ACKNOWLEDGMENTS The excellent technical assistance of Miss Ulrike Bolz and Mrs. Krista Lemmel is gratefully acknowledged. The authors wish to thank Dr. John Flectcher, Laboratory of Applied Studies, Division of Computer Research and Technology, National Institutes of Health, for performing the nonlinear least-squares curve-fitting calculations.

Submitted on April 19, 1976
Accepted on September 13, 1976







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics